Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion-Reference-Cited by-同舟云学术

Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion

Published:1997-09 Issue:1 Volume:17 Page:65-70
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

David Gilles,Abbas Nacer,Stevanin Giovanni,Dürr Alexandra,Yvert Gaël,Cancel Géraldine,Weber Chantal,Imbert Georges,Saudou Frédéric,Antoniou Eric,Drabkin Harry,Gemmill Robert,Giunti Paola,Benomar Ali,Wood Nick,Ruberg Merle,Agid Yves,Mandel Jean-Louis,Brice Alexis

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng0997-65.pdf

Reference44 articles.

1. Konigsmark, B.W. & Weiner, L.P. The olivopontocerebellar atrophies: a review. Medicine (Baltimore) 49, 227–241 (1970).

2. Berciano, J. Olivopontocerebellar atrophy: a review of 117 cases. J. Neurol. Sci. 53, 253–272 (1982).

3. Harding, A.E. The clinical features and classification of the late onset autosomal dominant cerebellar ataxias: a study of 11 families, including descendants of the ‘the Drew family of Walworth’. Brain 105, 1–28 (1982).

4. Harding, A.E. Clinical features and classification of inherited ataxias. Adv. Neurol. 61, 1–14 (1993).

5. Enevoldson, T.P., Sanders, M.D. & Harding, A.E. Autosomal dominant cerebellar ataxia with pigmentary macular dystrophy: a clinical and genetic study of eight families. Brain 117, 445–460 (1994).

Cited by 707 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Protein Quantity Control in Polyglutamine Spinocerebellar Ataxias;The Cerebellum;2024-07-25

2. Polyglutamine (PolyQ) Diseases: Navigating the Landscape of Neurodegeneration;ACS Chemical Neuroscience;2024-07-12

3. Altered Metabolic Signaling and Potential Therapies in Polyglutamine Diseases;Metabolites;2024-05-31

4. CAG repeat mosaicism is gene specific in spinocerebellar ataxias;The American Journal of Human Genetics;2024-05

5. Polyglutamine disease proteins: Commonalities and differences in interaction profiles and pathological effects;PROTEOMICS;2024-04-14